文献速递中医内科中药与中成药合理使用中医康复

基于TMT蛋白质组学揭示血府逐瘀汤对创伤性脑损伤大鼠的保护作用

TMT-based proteomics analysis reveals the protective effects of Xuefu Zhuyu decoction in a rat model of traumatic brain injury.
PubMed 文献 · J Ethnopharmacol · 2020-04-13

本研究采用控制性皮层撞击(CCI)大鼠模型,灌胃给予血府逐瘀汤(9 g/kg/d)或蒸馏水三天,通过神经功能评分、脑含水量、组织染色及TMT定量蛋白质组学分析,发现血府逐瘀汤改善神经功能、减轻脑水肿和细胞形态,并鉴定出17个受其调控的差异蛋白,主要涉及血小板激活和PI3K-Akt信号通路。

要点

  • 血府逐瘀汤可改善CCI大鼠神经功能并减轻脑水肿。
  • 蛋白质组学提示其作用与血小板激活和PI3K-Akt通路相关。
  • PLG和CD34被验证为受血府逐瘀汤调控的蛋白。

核心结论

  • 血府逐瘀汤通过多通路调控发挥治疗创伤性脑损伤的作用,蛋白质组学为其机制研究提供线索。

研究设计与样本

  • 采用CCI大鼠模型,灌胃血府逐瘀汤(9 g/kg/d)或蒸馏水三天,进行行为学、组织学和TMT蛋白质组学检测。

主要发现

  • 血府逐瘀汤改善CCI大鼠神经功能、减轻脑水肿并改善损伤区细胞形态。
  • 共鉴定6099个蛋白(FDR<1%),CCI/Sham组295个差异蛋白,XFZYD/CCI组804个,重叠105个,其中17个受血府逐瘀汤调控。
  • 生物信息学分析显示17个差异蛋白主要与血小板激活和PI3K-Akt信号通路相关,PLG和CD34经分子技术验证。

临床怎么用

  • 该研究为血府逐瘀汤治疗急性创伤性脑损伤提供了蛋白质组学层面的机制线索,提示其作用涉及血小板激活和PI3K-Akt通路。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

ETHNOPHARMACOLOGICAL RELEVANCE: Xuefu Zhuyu decoction (XFZYD) is a traditional Chinese herbal prescription. It is effective in treating traumatic brain injury (TBI). However, the underlying molecular mechanisms remain unclear. AIM OF THE STUDY: This study aimed to reveal the possible mechanisms of XFZYD in treating acute TBI through proteomics clues. MATERIALS AND METHODS: Controlled Cortical Impact (CCI) rats were given gavage administration of XFZYD (9 g/kg/d) or distilled water (equal volume) for three days. The Modified Neurological Severity Score (mNSS), brain water content, HE staining, Nissl staining and immunohistochemistry were performed to assess the effects of XFZYD for TBI treatment. Additionally, tandem mass tag-based (TMT) quantitative proteomics technology was applied to detect proteins of brain cortex. Bioinformatics analysis including Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways and Protein-protein interaction (PPI) networks were used to analyze differentially expressed proteins (DEPs). Bioinformatics Analysis Tool for Molecular mechanism of TCM (BATMAN-TCM) was conducted to anchor diseases and pathways. Besides, western blotting and immunofluorescence were exerted to verify related proteins. RESULTS: XFZYD improved neurologic functions, reduced encephaledema and ameliorated cell morphology around the injured area in CCI rats. A total of 6099 proteins were identified with false discovery rate (FDR) < 1%. Overlapping DEPs (105 DEPs) were identified (295 DEPs and 804 DEPs in CCI/Sham or XFZYD/CCI group, respectively). Of these DEPs, 17 were regulated by XFZYD. Bioinformatics analysis showed that the 17 DEPs were predominantly related to platelet activation and PI3K-Akt signaling pathway. Next, PLG and CD34 were verified with molecular biotechnology. CONCLUSIONS: XFZYD exerts therapeutic effects through multi-pathways regulation in the treatment of TBI. This work may provide proteomics clues for the continuation of research on TBI treatment with XFZYD.

来源:J Ethnopharmacol,查看原文。版权归原作者所有。

引用

  1. Zhou D, Liu J, Hang Y, et al. TMT-based proteomics analysis reveals the protective effects of Xuefu Zhuyu decoction in a rat model of traumatic brain injury. J Ethnopharmacol. 2020. PMID: 32298754. doi:10.1016/j.jep.2020.112826

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。